Balt’s Squid liquid embolic receives US FDA approval for adjunctive treatment for chronic subdural hematomas: Boston Friday, February 6, 2026, 17:00 Hrs [IST] Balt Inc, a global ...

A girl took the stand in a Florida courtroom on Wednesday to accuse her babysitter of beating her with a metal spoon and remote control if she misstated a word during English language lessons.

Balt, Inc., a global technology leader in neurovascular devices, today announced the Premarket Approval (PMA) of the Squid(TM) liquid embolic agent. Squid is approved for the embolization of the ...

Kanagawa Gov. Yuji Kuroiwa was hospitalized Tuesday and underwent surgery the following day for chronic subdural hematoma, ...

Yokohama, Feb. 5 (Jiji Press)--Kanagawa Governor Yuji Kuroiwa was hospitalized Tuesday and underwent surgery the following ...

Balt, Inc., a global technology leader in neurovascular devices, today announced the Premarket Approval (PMA) of the Squid liquid embolic agent. Squid is approved ...

Earlier this month, Medtronic received a new approval from the FDA for its decades-old liquid embolic system, extending its use to treat certain kinds of internal brain bleeds. Now, Johnson & Johnson ...

- TRUFILL n-BCA is now indicated for embolization of the middle meningeal artery (MMA) for the treatment of symptomatic subacute and Chronic Subdural Hematoma (cSDH) as an adjunct to surgery. - ...

Background: Microvascular decompression (MVD) is the primary treatment for cranial neurovascular compression syndromes. The most critical complication is hemorrhage during or after surgery. Although ...

Middle meningeal artery embolization with a liquid embolic is a minimally invasive adjunctive endovascular treatment for chronic subdural hematoma (cSDH). TRUFILL n‐butyl cyanoacrylate Liquid Embolic ...